Investigators from around the world are taking notice of our results in treating patients with mantle cell lymphoma. (MCL) In the below video, Dr. Laurie Sehn from the University of British Columbia shares her thoughts on Dr. Jia Ruan’s clinical trial of lenalidomide plus rituximab for previously untreated mantle cell lymphoma.
In the following video Dr. Ruan further discusses results of her trial with lenalidomide and rituximab combination for patients with MCL.
New Developments in Lymphoma 